Publication 4ème trim 2024

Bonjour à tous,
Vous trouverez ci-dessous les titres des publications des membres du réseau ENDOCAN TUTHYREF.
Félicitations aux auteurs!

Retrouvez les publications dans :   Espace membre

4ème trim 2024

Requête:

(RAHIM A[Author] OR ALGHUZLAN A[Author] OR BARDET S[Author] OR BARGE ML[Author] OR BATISSE-LIGNIER M[Author] OR BENISVY D[Author] OR BORSON-CHAZOT F[Author] OR Calcagno F[Author] OR BUFFET C[Author] OR Lussey-Lepoutre C[Author] OR Chevalier B[Author] OR CHOUGNET C[Author] OR Sajous C[Author] OR CIAPPUCCINI R[Author] OR Cogne M[Author] OR CRINIERE L[Author] OR CUNY T[Author] OR De la Fouchardière C[Author] OR DESAILLOUD R[Author] OR DO CAO C[Author] OR DRUI D[Author] OR DRUTEL A[Author] OR DYGAI-COCHET I[Author] OR EDET-SANSON A[Author] OR Gilly O[Author] OR GODBERT Y[Author] OR GROUSSIN L[Author] OR GRUNENWALD S[Author] OR Lasolle H[Author] OR HESCOT S[Author] OR ILLOUZ F[Author] OR Borget I[Author] OR JANNIN A[Author] OR KARABAJAKIAN A[Author] OR KELLY A[Author] OR LABOUREAU S[Author] OR LAMBERT A[Author] OR LAMARTINA L[Author] OR Haissaguerre M[Author] OR MULLER M[Author] OR NARCISO B[Author] OR Pinochet P[Author] OR Raymond P[Author] OR RODIEN P[Author] OR ROUDAUT N[Author] OR SALAS S[Author] OR SCHNEEGANS O[Author] OR SCHVARTZ C[Author] OR Castellnou S[Author] OR VELAYOUDOM-CEPHISE FL[Author] OR VERA P[Author] OR ZALZALI M[Author] OR ZANETTA S[Author] OR ZERDOUD S[Author] OR HADOUX J[Author] OR Nascimento C[Author] OR Eberle MC[Author] OR CATARGI B[Author] OR CHABRE O[Author] OR KLEIN M[Author] OR LEENHARDT L[Author] OR NICOLLI P[Author] OR TAIEB D[Author] OR RUSU D[Author] OR Schlumberger M[Author] OR Leboulleux S[Author] OR TUTHYREF OR ENDOCAN-RENATEN) AND ("thyroid neoplasms"[Mesh] OR (("Thyroid"[tw] OR "Thyroid Gland"[Mesh]) AND ("Neoplasms"[Mesh] OR "neoplas*"[tw] OR "tumor*"[tw] OR "tumour*"[tw] OR "cancer*"[tw] OR "lymphoma*"[tw] OR "malignan*"[tw] OR "oncolog*"[tw] OR "carcinom*"[tw] OR "adenoma*"[tw] OR "TUTHYREF" OR "ENDOCAN-RENATEN"))) AND ((2024/10/01[edat]: 2025/01/02[edat]) OR (2024/10/01[epdat]: 2025/01/02[epdat]) OR (2024/10/01[dp]: 2025/01/02[dp]))

Résultat :

  1. Alsugair Z, Descotes F, Lopez J, Lasolle H, Chazot FB, Lifante JC, Decaussin-Petrucci M. Clinically aggressive follicular cell-derived thyroid carcinoma: A comprehensive series with histomolecular characterization and discovery of novel gene fusions. Hum Pathol. 2024 Nov;153:105674. doi: 10.1016/j.humpath.2024.105674. Epub 2024 Oct 28. PMID: 39490534.

  2. Ansart F, de Ponthaud C, Buffet C, Menegaux F, Gaujoux S, Chereau N. One- or Two-Step Total Thyroidectomy for Cancer Indications: A 20-Year Retrospective Study from a Referral Center. Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16707-6. Epub ahead of print. PMID: 39739263.

  3. Attia A, Touma E, Lussey-Lepoutre C, Ghander C, Jouinot A, Roy M, Housni S, Chereau N, Menegaux F, Leenhardt L, Buffet C. Consideration of Early Dynamic Risk Stratification to Guide Discharge from Oncologic Follow-Up in Patients with Differentiated Thyroid Cancer. Thyroid. 2024 Dec;34(12):1465-1475. doi: 10.1089/thy.2024.0119. Epub 2024 Oct 14. PMID: 39287064.

  4. Bani MA, Moog S, Suciu V, Lamartina L, Ghuzlan AA. Nouveautés en pathologie thyroïdienne : classification OMS 2022, système Bethesda 2023, biologie moléculaire et testing moléculaire. Bull Cancer. 2024 Oct;111(10S1):10S5-10S18. French. doi: 10.1016/S0007-4551(24)00404-1. PMID: 39505436.

  5. Chereau N, Gaujoux S, Ghander C, Bertocchio JP, Buffet C, Menegaux F. Parathyroid hormone-based algorithm reduces complications after total thyroidectomy. Surgery. 2025 Feb;178:108933. doi: 10.1016/j.surg.2024.10.024. Epub 2024 Nov 29. PMID: 39613653.

  6. Ciappuccini R, Nascimento C, Edet-Sanson A, Bardet S. Médecine nucléaire et cancers de la thyroïde en 2024 : iode 131, TEP et nouvelles approches théranostiques. Bull Cancer. 2024 Oct;111(10S1):10S64-10S72. French. doi: 10.1016/S0007-4551(24)00409-0. PMID: 39505438.

  7. Do Cao C, Danais A, Schwartz P, Godbert Y. Le cancer thyroïdien différencié réfractaire à l’iode : quelle prise en charge en 2024 ? Bull Cancer. 2024 Oct;111(10 Suppl 1):10S31-10S41. French. doi: 10.1016/S0007-4551(24)00406-5. PMID: 39505434.

  8. Dolfi M, Bardet S. Selpercatinib – première ligne du cancer médullaire de la thyroïde avancé, progressif et muté RET [Selpercatinib - First-line in advanced progressive RET-mutant medullary thyroid cancer]. Bull Cancer. 2024 Dec;111(12):1082-1083. French. doi: 10.1016/j.bulcan.2024.06.005. Epub 2024 Oct 10. PMID: 39389875.

  9. Jannin A, Lugat A, Escande A, Godbert Y, Wasserman J, Do Cao C, Hadoux J. Quelles avancées dans la prise en charge du carcinome anaplasique de la thyroïde en 2024 ? Bull Cancer. 2024 Oct;111(10 Suppl 1):10S42-10S52. French. doi: 10.1016/S0007-4551(24)00407-7. PMID: 39505435.

  10. Lamartina L, Grunenwald S, Roy M, Hartl D, Buffet C. Prise en charge des cancers thyroïdiens localisés de souche vésiculaire différenciée. Bull Cancer. 2024 Oct;111(10S1):10S19-10S30. French. doi: 10.1016/S0007-4551(24)00405-3. PMID: 39505432.

  11. Lasolle H, Borson-Chazot F, Gauduchon T, Haissaguerre M, Illouz F, Lifante JC, Lussey-Lepoutre C, Prunier D, Sajous C, Varnier R, Hadoux J. La prise en charge des cancers médullaires de la thyroïde en 2024. Bull Cancer. 2024 Oct;111(10S1):10S53-10S63. French. doi: 10.1016/S0007-4551(24)00408-9. PMID: 39505437.

  12. Leboulleux S, Bournaud C, Chougnet CN, Lamartina L, Zerdoud S, Do Cao C, Catargi B, Dygai I, Kelly A, Barge ML, Vera P, Rusu D, Schneegans O, Roux J, Raymond P, Benisvy D, Eberle MC, Bidault S, Nascimento C, Bastie D, Giraudet AL, Bardet S, Le Moullec N, Roudaut N, Drui D, Godbert Y, Zalzali M, Drutel A, Morel O, Velayoudom FL, Al Ghuzlan A, Schlumberger M, Buffet C, Borget I. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial. Lancet Diabetes Endocrinol. 2025 Jan;13(1):38-46. doi: 10.1016/S2213-8587(24)00276-6. Epub 2024 Nov 22. PMID: 39586309.

  13. Legrand A, Bernier MO, Bressand A, Buffet C, Mandin C, Menegaux F, Soret M, Broggio D, Bassinet C, Huet C, Leenhardt L, Lussey-Lepoutre C, Baudin C. Health- related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after study. Qual Life Res. 2024 Oct;33(10):2721-2731. doi: 10.1007/s11136-024-03721-0. Epub 2024 Jun 22. PMID: 38907832.

  14. Mostowski R, de Pontville M, Bardet S, Ciappuccini R. False-Positive Radioiodine Uptake Related to Posttraumatic Scab Demonstrated by SPECT/CT in a Patient With Differentiated Thyroid Cancer. Clin Nucl Med. 2025 Jan 1;50(1):88-90. doi: 10.1097/RLU.0000000000005563. Epub 2024 Nov 12. PMID: 39529260.

  15. Potonnier W, Guillerm E, Bigorgne C, Ghander C, Roy M, Coulet F, Ansart F, Menegaux F, Leenhardt L, Brocheriou I, Deniziaut G, Buffet C. Performance of the AmpliSeq NGS Panel in Thyroid Nodules with Indeterminate Cytology. Eur Thyroid J. 2024 Dec 1:ETJ-24-0160. doi: 10.1530/ETJ-24-0160. Epub ahead of print. PMID: 39637043.